AtriCure–developer of Isolator synergy ablation system for persistent atrial fibrillation—has entered into a definitive agreement to acquire SentreHEART, a privately held developer of percutaneous left atrial appendage (LAA) management solutions (including the LARIAT device). Under the terms of the agreement to acquire SentreHEART, the transaction consideration consists of an upfront payment of approximately $40 [...]